Effect of astrocyte GPER on the optic nerve inflammatory response following optic nerve injury in mice

Xuan Wang, Jiaxing Zhou, Yuwen Wang, Xue Li, Qiumei Hu, Linlin Luo, Xuemei Liu, W. Liu, Jian YeHeliyon 2024 · DOI

TL;DR

This study reveals that activating the G protein-coupled estrogen receptor (GPER) in astrocytes significantly reduces inflammation and protects retinal ganglion cells (RGCs) after optic nerve injury in mice. This suggests GPER is a promising therapeutic target for traumatic optic neuropathy (TON).

What Problem Does This Paper Address?

Traumatic optic neuropathy (TON), often caused by optic nerve crush (ONC), leads to significant vision loss due to the death of retinal ganglion cells (RGCs) and their axons. A key driver of this damage is the inflammatory response triggered by activated astrocytes, which release harmful inflammatory factors. While astrocytes are known to contribute to this pathology, the specific molecular mechanisms that regulate their activation and subsequent inflammatory cascade after injury are not fully understood. This paper aims to elucidate the role of GPER, a receptor found on astrocytes, in modulating this inflammatory response and protecting RGCs.

Methods

The researchers employed a multi-pronged approach:

  • In vivo studies: They used a mouse model of ONC. GPER was activated using a specific agonist (G-1) and inhibited using an antagonist (G15). The effects on astrocyte activation (measured by GFAP expression), inflammatory factor levels (NFκB, p-NFκB, IL-1β, TNF-α), and RGC survival (using BRN3A staining) were assessed.
  • In vitro studies: Primary astrocytes were isolated and cultured. These astrocytes were then stimulated with glutamate to mimic injury-induced activation. The effects of GPER activation (G-1) and inhibition (G15) on astrocyte activation and inflammatory factor release were investigated.
  • Immunofluorescence (IF): This technique was used to visualize the expression and co-localization of GPER with GFAP (an astrocyte marker) in optic nerve tissues and cultured astrocytes.
  • Western Blotting (WB): This method was used to quantify the protein levels of GFAP, NFκB, p-NFκB, IL-1β, and TNF-α in both optic nerve tissue and cultured astrocytes.
  • Enzyme-Linked Immunosorbent Assay (ELISA): This assay was used to measure the levels of inflammatory cytokines (IL-1β and TNF-α) in the supernatant of cultured astrocytes.
  • Statistical Analysis: Standard statistical methods, including two-way ANOVA and Tukey's post hoc test, were used to analyze the data.

Datasets

Not discussed in the paper. The study primarily relies on experimental data generated from animal models and cell cultures.

Key Insights and Ideas

  • GPER is a key regulator of astrocyte activation: The study strongly suggests that GPER plays a critical role in controlling how astrocytes respond to injury. Activating GPER calms them down, while blocking it makes them more reactive.
  • GPER's anti-inflammatory action is mediated by NFκB: A significant finding is that GPER's ability to reduce inflammation appears to be directly linked to its suppression of the NFκB signaling pathway. This pathway is a central hub for inflammatory responses.
  • GPER activation is neuroprotective: Beyond just reducing inflammation, activating GPER directly leads to better survival of RGCs, which are the cells lost in TON and responsible for vision. This highlights a direct link between reduced inflammation and neuronal survival.
  • GPER's dual role: The study elegantly demonstrates that GPER activation (G-1) is beneficial, while GPER inhibition (G15) is detrimental, leading to increased inflammation and RGC loss. This provides a clear direction for therapeutic intervention.

Key Results

  • GPER co-localizes with GFAP: In optic nerve tissue, GPER was found to be highly co-localized with GFAP, indicating its presence on astrocytes.
  • G-1 reduces astrocyte activation and inflammation: In vivo, treatment with G-1 (GPER agonist) significantly decreased GFAP expression and the levels of inflammatory factors (NFκB, p-NFκB, IL-1β, TNF-α) in the optic nerve after ONC.
  • G15 exacerbates inflammation: Conversely, treatment with G15 (GPER inhibitor) led to increased GFAP expression and higher levels of inflammatory factors.
  • G-1 promotes RGC survival: G-1 treatment significantly increased the number of surviving RGCs at both 7 and 14 days post-ONC.
  • G15 reduces RGC survival: G15 treatment significantly decreased RGC survival.
  • In vitro validation: Similar effects were observed in cultured astrocytes, where GPER activation reduced glutamate-induced GFAP expression and inflammatory factor release, while G15 had the opposite effect.
  • NFκB pathway involvement confirmed: Inhibition of NFκB with PDTC in both in vivo and in vitro settings mimicked the protective effects of GPER activation and blocked the detrimental effects of GPER inhibition, strongly supporting the NFκB pathway as the mediator.

Limitations and Future Work

  • Specificity of GPER: The authors acknowledge that GPER is not exclusive to optic nerve astrocytes and may be present in other cell types. While their in vitro experiments focused on astrocytes, they suggest that GPER activation might exert indirect effects on other cells.
  • Mechanism of RGC survival: While the study shows GPER activation protects RGCs, the precise downstream mechanisms by which reduced inflammation leads to RGC survival are not fully defined.
  • Complex cellular interactions: The authors note that complex interactions exist between different cell types in the context of ONC, which were not fully explored in this study.
  • Further investigation needed: The paper highlights the need for further investigation into the specific mechanisms of GPER's regulation of astrocyte activation and its role in promoting RGC survival after inflammatory factor reduction.

Summary updated

Abstract

Activated astrocytes are a primary source of inflammatory factors following traumatic optic neuropathy (TON). Accumulation of inflammatory factors in this context leads to increased axonal damage and loss of retinal ganglion cells (RGCs). Therefore, in the present study, we explored the role of the astrocyte G protein-coupled estrogen receptor (GPER) in regulating inflammatory factors following optic nerve crush (ONC), and analyzed its potential regulatory mechanisms. Overall, our results showed that GPER was abundantly expressed in the optic nerve, and co-localized with glial fibrillary acidic proteins (GFAP). Exogenous administration of G-1 led to a significant reduction in astrocyte activation and expression of inflammation-related factors (including IL-1β, TNF-α, NFκB, and <i>p</i>-NFκB). Additionally, it dramatically increased the survival of RGCs. In contrast, astrocytes were activated to a greater extent by exogenous G15 administration; however, RGCs survival was significantly reduced. <i>In vitro</i>, GPER activation significantly reduced astrocyte activation and the release of inflammation-related factors. In conclusion, activation of astrocyte GPER significantly reduced ONC inflammation levels, and should be explored as a potential target pathway for protecting the optic nerve and RGCs after TON.
BibTeX
@inproceedings{wang2024effect,
  author = {Xuan Wang and Jiaxing Zhou and Yuwen Wang and Xue Li and Qiumei Hu and Linlin Luo and Xuemei Liu and W. Liu and Jian Ye},
  title = {{Effect of astrocyte GPER on the optic nerve inflammatory response following optic nerve injury in mice}},
  booktitle = {Heliyon},
  year = {2024},
  doi = {10.1016/j.heliyon.2024.e29428},
}
Figure